Health

[SPECIAL CONTENT] Fighting Against COVID-19

"Health" Activities

Fulfill Unmet Medical Needs (Priority Issue 1)

Targets for FY2030	Major activities of FY2021	Self- evalution
Develop and disseminate new treatments based on regenerative medicine and cell therapy	Kicked Off Operations at its New, State-of-the-Art Cell Culture Media Manufacturing Facility in Europe to expand cell culture media production capacity Decided and implemented a large-scale capital investment in European and U.S. bases to further increase production capacity for biologics Acquired a Dedicated Cell Therapy Manufacturing Facility from a U.S. bio-venture, Atara Biotherapeutics, Inc. Acquired Shenandoah Biotechnology Inc., a U.S. biotechnology company	〇

Learn more

Improve Accessibilities to Medical Services (Priority Issue 2)

Targets for FY2030	Major activities of FY2021	Self- evalution
(1) Reducing burden on medical professionals by utilizing IT	Obtained recommendation of Stop TB Partnership that combines a portable X-ray device and DR cassette as a tuberculosis examination system Selected under the Asian DX Promotion Program of the Ministry of Economy, Trade and Industry for study into the efficacy of AI-based diagnostic imaging systems in health examination services for developing countries Introduced our AI-driven products and services to 83 countries/regions	〇
(2) Development and dissemination of infectious disease diagnostic system to contribute to global health
(3) Offering technical diagnosis training and spreading effective health practices to emerging countries
(4) Improve medical accessibility by introducing our AI-driven products/services to all 196 countries/regions

Learn more

Efforts to Eradicate Tuberculosis

Contribute to Early Disease Detection (Priority Issue 3)

Targets for FY2030	Major activities of FY2021	Self- evalution
Reduce the physical burden through widespread and expanded use of medical diagnostic systems	Obtained recommendation of Stop TB Partnership that combines a portable X-ray device and DR cassette as a tuberculosis examination system Selected under the Asian DX Promotion Program of the Ministry of Economy, Trade and Industry for study into the efficacy of AI-based diagnostic imaging systems in health examination services for developing countries	〇

Efforts to Eradicate Tuberculosis

Contribute to Health Promotion and Beauty (Priority Issue 4)

Targets for FY2030	Major activities of FY2021	Self- evalution
(1) Promote to prolong healthy lives	Launched a food with function claims, by adding functions to increase energy consumption during daily activities and exercise in Japan Launched a Skin Care Brand which responds to skin concerns such as dry and sensitive skin in Japan	〇
(2) Promote support for women’s empowerment		〇

Promote Management of a Healthy Workplace (Priority Issue 5)

Targets for FY2030	Major activities of FY2020	Self- evalution
Promote management of health and productivity to maintain employees’ vitality	Selected for the Health & Productivity Stock Selection Program for two consecutive years Introduced the "Seven Health Behaviors in the Fujifilm Group" to acquire healthy lifestyles, and took a survey of the level of implementation for group employees in Japan Implemented of "Mental Health Care at COVID-19 epidemic" an e-learning on health management for group employees in Japan	〇

Data and Information：Health, Safety and Wellness of Employees

PDF：1.61MB

Learn more

Future Activities and Targets

As a company that supports the creation of cutting-edge therapeutic drugs, we will develop a "one-site one-stop" system that enables us to provide integrated contact development services from the process development to the formulation and final packaging of various biopharmaceuticals including antibody drugs and hormonal formulations, from small quantities to mass production. In addition, in order to contribute to the deterrence of the expansion of COVID-19, we will continue to provide a variety of medical equipment, including digital X-ray imaging device and ultrasound diagnostic equipment, and process development and contract manufacturing for vaccines and other products at pharmaceutical companies.

In the healthcare IT field, under the REiLI brand, we will develop and commercialize AI technologies that support the workflow of healthcare professionals, combining CT, MRI, X-ray diagnostic equipment, and a wide range of other modalities with IT technologies incorporating state-of-the-art AI systems.

Fulfill Unmet Medical Needs (Priority Issue 1)

Improve Accessibilities to Medical Services (Priority Issue 2)

Contribute to Early Disease Detection (Priority Issue 3)

Contribute to Health Promotion and Beauty (Priority Issue 4)

Promote Management of a Healthy Workplace (Priority Issue 5)

Future Activities and Targets

Activities of each operating company

Initiatives for Occupational Health and Safety (Fujifilm)

Work Safety/Health Promotion (FUJIFILM Business Innovation)

Related Content